Evidence map›Paper›PMID 42206636›Full record

ReviewChemical reviews2026

Membrane Protein Insertion in Cells: Principles, Pathways, and Quality Control.

Hadas Peled-Zehavi, Reut Yemini, Nir Fluman

Abstract readReview
In one paragraph

Review in Chemical reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hadas Peled-ZehaviDepartment of Biomolecular Sciences, Weizmann Institute of Science, 234 Herzl St. PO Box 26, Rehovot 7610001, Israel.
Reut YeminiDepartment of Biomolecular Sciences, Weizmann Institute of Science, 234 Herzl St. PO Box 26, Rehovot 7610001, Israel.
Nir FlumanDepartment of Biomolecular Sciences, Weizmann Institute of Science, 234 Herzl St. PO Box 26, Rehovot 7610001, Israel.ORCID 0000-0001-9909-0779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integral membrane proteins comprise at least a quarter of every proteome. To fold and function properly, these proteins must insert into the correct membrane with the proper topology and orientation. Although their transmembrane helices are chemically compatible with the bilayer, insertion inside cells is not a simple spontaneous event. It must occur in a crowded environment, at the correct membrane, and it often involves challenges such as transferring hydrophilic segments across the bilayer or accommodating helices that are only marginally compatible with it. Cells therefore rely on dedicated systems that direct membrane proteins to the membrane, mediate their insertion, and monitor the process to ensure that it occurs correctly. This review outlines the principles that govern membrane protein insertion in cells and explains how transmembrane sequence features interact with the machineries that mediate their entry into the bilayer. We highlight the major insertion systems of bacteria and eukaryotes and the auxiliary factors that support them, and describe how these pathways accommodate the broad range of membrane protein architectures found in cells, from single-pass proteins to complex multispanning transporters. We also discuss how cells maintain accuracy when insertion fails, through mechanisms that detect and resolve misinsertion. Together, these concepts present membrane protein insertion as a coordinated, adaptable, and safeguarded process, shaped by the interplay between sequence properties, membrane environments, and the machinery responsible for building the membrane proteome.

Indexed as

Cell MembraneMembrane ProteinsAnimalsHumansMembrane Proteins

Identifiers

PMID42206636
PMCPMC13261788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.